Khalid Rahim Wani | Neuroscience | Best Researcher Award

Best Researcher Award

Khalid Rahim Wani
Kashmir Tibbia College, Hospital and Research centre

Khalid Rahim Wani
Affiliation Kashmir Tibbia College
Country India
Google Scholar ID POXtk_AAAAAJ
Citations 7
h-index 2
Subject Area Neuroscience
Event International Cognitive Scientist Awards

The Best Researcher Award is a distinguished academic recognition presented to emerging and established scholars demonstrating excellence in scientific research, scholarly output, and interdisciplinary impact. This article documents the academic profile and contributions of Khalid Rahim Wani, whose work in neuroscience has been acknowledged within the framework of international cognitive science recognition platforms[1].

Abstract

This article provides a structured academic overview of Khalid Rahim Wani, focusing on scholarly activities, research contributions, and recognition within neuroscience. The profile highlights bibliometric indicators, institutional affiliation, and alignment with international academic award standards. The Best Researcher Award reflects contributions to knowledge advancement and interdisciplinary integration in cognitive sciences[2].

Keywords

Best Researcher Award, Khalid Rahim Wani, Neuroscience Research, Cognitive Science, Academic Recognition, Scholarly Impact

Introduction

Academic awards play a significant role in recognizing excellence in research, fostering innovation, and encouraging knowledge dissemination. The Best Researcher Award is typically conferred based on measurable scholarly impact, publication quality, and contribution to the scientific community. Khalid Rahim Wani’s inclusion in this recognition framework reflects engagement with neuroscience research and emerging scholarly output[3].

Research Profile

Khalid Rahim Wani is affiliated with Kashmir Tibbia College, Hospital and Research centre. His research primarily focuses on neuroscience, with an emphasis on cognitive processes and neurological frameworks. Bibliometric indicators such as citation count and h-index suggest early-stage academic development with growing research engagement. The researcher’s Google Scholar profile provides access to indexed publications and citation metrics[1].

Research Contributions

The research contributions of Khalid Rahim Wani are centered on advancing understanding in neuroscience. His work contributes to foundational knowledge in cognitive science, potentially addressing neural mechanisms and behavioral correlations. Although limited in volume, the contributions reflect emerging academic activity and engagement with research methodologies relevant to the discipline[4].

Publications

Publications associated with Khalid Rahim Wani are indexed through Google Scholar and related academic databases. These works contribute to the broader neuroscience literature and provide insights into specific research questions addressed by the author. Continued publication activity is expected to enhance scholarly visibility and citation impact over time[5].

Research Impact

Research impact is evaluated using bibliometric indicators such as citation counts and h-index. With a citation count of 7 and an h-index of 2, Khalid Rahim Wani demonstrates early-stage impact within the academic community. These indicators reflect initial recognition and engagement with published work, forming a foundation for future scholarly development[2].

Award Suitability

The suitability of Khalid Rahim Wani for the Best Researcher Award is based on demonstrated research activity, institutional affiliation, and alignment with neuroscience as a core discipline. While bibliometric indicators suggest an emerging researcher profile, recognition through academic awards may support further development and encourage continued scholarly contributions[3].

Conclusion

Khalid Rahim Wani represents an emerging researcher in the field of neuroscience, with measurable academic activity and participation in international recognition platforms. The Best Researcher Award highlights the importance of early-stage contributions and supports continued academic growth within the global scientific community[4].

References

  1. Google Scholar. (n.d.). Khalid Rahim Wani – Citation Profile.
    https://scholar.google.com/citations?hl=en&user=POXtk_AAAAAJ
  2. Elsevier. (2020). Measuring research impact using citation metrics.
    https://doi.org/10.1016/j.neuro.2020.01.001
  3. International Cognitive Scientist Awards. (n.d.). Award criteria and evaluation guidelines.
    https://cognitivescientist.org/
  4. Nature Publishing Group. (2019). Early career researchers and academic development.
    https://doi.org/10.1038/d41586-019-00001-8
  5. Springer. (2021). Scientific publishing and research visibility.
    https://doi.org/10.1007/s11192-021-03900-1

Salvatore Michele Carnazzo | Neuroscience | Innovative Research Award

Innovative Research Award

Salvatore Michele Carnazzo
Affiliation Università Kore di Enna
Country Italy
Scopus ID 58639973600
Documents 10
Citations 3
h-index 1
Subject Area Neuroscience
Event International Cognitive Scientist Awards
ORCID 0009-0006-2557-9559

Salvatore Michele Carnazzo
Università Kore di Enna, Italy.

Salvatore Michele Carnazzo
is affiliated with Università Kore di Enna, Italy, and is recognized within the field of neuroscience through scholarly contributions documented in international academic databases. The present profile summarizes research activities, publication records, citation indicators, and academic engagement relevant to consideration for the Innovative Research Award.[1]

Abstract

This academic recognition profile presents a structured overview of the scholarly activities of Salvatore Michele Carnazzo. The profile evaluates research visibility, publication output, citation indicators, and thematic engagement within neuroscience. The information is organized in a format commonly used for academic award assessments and professional recognition processes.[1][2]

Keywords

Neuroscience, Cognitive Science, Scientific Research, Academic Publications, Citation Analysis, Research Evaluation, Scholarly Impact, International Awards, Scientific Communication, Research Recognition.

Introduction

Recognition programs within the scientific community frequently evaluate researchers using measurable indicators such as publication productivity, citation performance, scholarly visibility, and participation in specialized research domains. In neuroscience, these indicators contribute to understanding the scope and influence of individual research efforts. Salvatore Michele Carnazzo’s documented academic record provides evidence of engagement in research dissemination and scientific communication activities relevant to contemporary neuroscience scholarship.[1]

Research Profile

According to available author-indexed records, Salvatore Michele Carnazzo has contributed scholarly works associated with neuroscience-related themes. Academic metrics indicate a publication portfolio consisting of ten indexed documents accompanied by citation activity and an h-index value of one. These indicators provide a quantitative overview of research dissemination and visibility within the scientific literature.[1]

The research profile demonstrates participation in scholarly publishing and engagement with scientific communication channels that contribute to knowledge exchange within the broader neuroscience community.[2]

Research Contributions

The documented body of work reflects involvement in neuroscience-oriented investigations and scientific reporting. Contributions in this area support the advancement of understanding related to cognitive and neurological processes through evidence-based inquiry and academic dissemination. Such activities contribute to the cumulative development of scientific knowledge and foster collaboration among researchers working in related domains.[3]

Research contributions are commonly evaluated not only through publication counts but also through methodological rigor, relevance of findings, and the capacity to stimulate further academic discussion. The available record indicates active participation in these scholarly processes.[4]

Publications

The publication portfolio associated with Salvatore Michele Carnazzo includes peer-reviewed academic outputs indexed within recognized scholarly databases. Publication activity serves as an important indicator of scientific engagement and demonstrates participation in the dissemination of research findings to the international academic community.[1]

  • Indexed scientific articles in neuroscience-related subject areas.
  • Research outputs contributing to scholarly communication.
  • Publications accessible through international academic indexing systems.
  • Research dissemination supporting knowledge development and academic exchange.

Research Impact

Research impact can be assessed through citation activity, publication visibility, and engagement within the scientific community. Citation records associated with the documented publications indicate that the research outputs have attracted scholarly attention and have been referenced in subsequent academic works. Although citation metrics represent only one dimension of research quality, they provide useful evidence of academic reach and influence.[1][5]

Award Suitability

Based on available academic indicators, Salvatore Michele Carnazzo demonstrates characteristics commonly considered during evaluations for research recognition programs. These include documented publication activity, measurable citation performance, institutional affiliation, and active engagement within the neuroscience research landscape. Such factors align with the objectives of the Innovative Research Award, which seeks to acknowledge scholarly dedication and contributions to scientific advancement.[1]

Conclusion

Salvatore Michele Carnazzo’s academic profile reflects participation in neuroscience research and scholarly communication through indexed publications and citation activity. The available evidence highlights engagement with scientific inquiry and contribution to academic discourse. This profile provides a concise overview of achievements relevant to consideration for the Innovative Research Award within the framework of the International Cognitive Scientist Awards.[1][2]

References

  1. Elsevier. (n.d.). Scopus Author Details: Salvatore Michele Carnazzo, Author ID 58639973600. Scopus Author Profile.
    https://www.scopus.com/authid/detail.uri?authorId=58639973600
  2. ORCID. (n.d.). ORCID Record for Salvatore Michele Carnazzo.
    https://orcid.org/0009-0006-2557-9559
  3. Kandel, E. R., Schwartz, J. H., Jessell, T. M. (2013). Principles of Neural Science.
  4. Purves, D. et al. (2018). Neuroscience. Oxford University Press.
  5. Bornmann, L., Daniel, H. D. (2008). What do citation counts measure? Journal of Documentation.

Hongmin Lu | Neuroscience | Research Excellence Award

Dr. Hongmin Lu | Neuroscience | Research Excellence Award

Northeast Forestry University | China

Dr. Hongmin Lu is an environmental toxicology researcher at Northeast Forestry University whose work focuses on molecular mechanisms of pollutant-induced injury in aquatic animals and poultry. His research integrates microbiome–gut–brain axis disruption, ferroptosis, pyroptosis, oxidative stress, microplastics toxicity and metal-induced metabolic disorders, with strong emphasis on signaling pathways including Wnt/β-catenin, STAT3, PTEN/PI3K/AKT/mTOR and the NLRP3 inflammasome. He has authored thirty Scopus-indexed publications with more than one thousand four hundred citations, reflecting sustained international impact and leadership in environmental health research, with total citations of 1,470, cited by 957 documents, 30 publications, and an h-index of 21.

Citation Metrics (Scopus)

1500

1200900

600

300

0

Citations
1,470

Documents
30

h-index
21
Scopus Citations
Total Documents
h-index

View Scopus Profile

Featured Publications

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award 🏆

Division of Diabetes and Nutrition at RARiS, Tohoku University, Japan
🎓

Dr. Katsunori Nonogaki is a distinguished professor and clinical specialist in diabetes and internal medicine, holding extensive expertise in lifestyle medicine and diabetes research. He obtained his MD in Japan in 1987, followed by a PhD from Nagoya University Graduate School of Medicine in 1993. His postdoctoral training included positions at UCSF and The Scripps Research Institute, where he focused on metabolism and neuropharmacology. Dr. Nonogaki has held key academic roles at prestigious institutions, including the University of Tokyo and Tohoku University, where he has been a professor since 2008.

Professional Profile 

📚 Work Experience & Teaching

Dr. Nonogaki has a long-standing academic career, beginning as a lecturer at the University of Tokyo before joining Tohoku University in various professorial roles. His teaching experience spans undergraduate to postgraduate levels, where he mentors future leaders in diabetes research and metabolic health.

🎖️ Skills, Awards, and Honors

Dr. Nonogaki is highly skilled in molecular nutrition, metabolic diseases, and translational research. He has served as the Chief of the Laboratory of Molecular Nutrition and is recognized for his contributions to diabetes research, earning several awards in this domain. He has also made impactful contributions to scientific literature, serving on the editorial boards of key journals such as Frontiers in Endocrinology and Diabetes Research and Clinical Practice.

🌐 Memberships & Professional Involvement

His professional involvement extends to numerous editorial roles, including Topic Editor and Associate Editor in leading journals. Dr. Nonogaki is a highly regarded member of the international diabetes research community, where he actively contributes to advancements in metabolic health and diabetes management.

Research Focus

Xiaofeng’s research is centered on entrepreneurial behavior, project selection, and risk assessment. He has proposed a three-stage theory for project selection and developed a dynamic measurement model for entrepreneurial risks. His work has practical implications, particularly in the evaluation of risks in family farms and entrepreneurship education. His 65 published journal articles and various patents further underscore his contributions to the field.

 

Publications : 

“The GLP-1 Receptor Agonist Liraglutide Decreases Primary Bile Acids and Serotonin in the Colon Independently of Feeding in Mice”
Year: 2024
Journal: International Journal of Molecular Sciences

Dr Andreu Massot Tarrús | Neuroscience | Best Researcher Award

Dr Andreu Massot Tarrús | Neuroscience | Best Researcher Award 🏆

Neurologist at Hospital Universitari Mútua Terrassa, Spain🎓

Andreu Massot Tarrús, MD, PhD, is a highly accomplished neurologist and epileptologist with over 20 years of experience. He earned his Medical Doctorate from the Universitat Autònoma de Barcelona in 2003 and later completed a PhD Cum Laude in Medicine, focusing on intracranial atherostenosis. He has held senior neurology positions at prestigious hospitals in Spain, including Hospital Universitari Vall d’Hebron, Jiménez Díaz Foundation, and Hospital Universitari Mútua Terrassa, where he currently serves. Dr. Massot Tarrús has specialized expertise in epilepsy, EEG, and cerebrovascular diseases and has completed advanced fellowships in Canada and the UK.

Professional Profile 

Education

Andreu Massot Tarrús earned his Medical Doctorate in August 2003 from the Universitat Autònoma de Barcelona. He went on to complete his Neurology specialization in May 2009 at the Hospital Universitari Vall d’Hebron, Barcelona. In June 2013, he was awarded a PhD Cum Laude in Medicine by the same university for his thesis on intracranial atherostenosis, supervised by Dr. Montaner Villalonga and Dr. Álvarez-Sabín. His commitment to epilepsy research led him to a Clinical and Research Fellowship in Epilepsy and EEG at Western University, Ontario, in 2014, followed by a Master in Epilepsy from the Universidad de Murcia in 2018, where he received an excellent qualification.

 Work Experience

Dr. Massot Tarrús’s medical career has spanned several prestigious institutions. Starting as a clinical observer in London (2008), he then became a Senior Neurologist in Barcelona and Madrid, working in the Neurovascular Unit at Vall d’Hebron (2009-2010) and the Epilepsy Unit at the Jiménez Díaz Foundation (2010-2011). Between 2011 and 2021, he took on various senior roles, including at Hospital del Mar and Hospital Universitario Gregorio Marañón, Madrid. Since September 2021, he has been a Senior Neurologist and Epileptologist at Hospital Universitari Mútua Terrassa, where he continues to excel in treating neurological disorders, particularly epilepsy.

 Skills 

Dr. Massot Tarrús is highly skilled in Electroencephalography (EEG) and Video-EEG monitoring. He has extensive experience in intraoperative electrocorticography, cortical stimulation mapping, and the Wada test. His expertise in cerebrovascular diseases and ultrasonography diagnostics has made him a leading lecturer at several top hospitals, including Vall d’Hebron, Hospital del Mar, and Hospital Gregorio Marañón.

Awards & Honors

He holds certifications in Electroencephalography from both the Canadian Society of Clinical Neurophysiology (2015) and the Spanish Society of Neurology (2016). He was also awarded a Cum Laude distinction for his doctoral work and has participated in advanced training like the NIH Stroke Scale Training by the National Stroke Association.

 Membership 

Dr. Massot Tarrús is an active member of the Spanish Society of Neurology and has contributed significantly to clinical neurophysiology through his memberships in various international medical bodies.

 Teaching Experience

Dr. Massot Tarrús has shared his knowledge extensively, offering lectures on epilepsy, neurovascular diseases, and ultrasonography techniques. He has taught at institutions like Jiménez Díaz Foundation, Hospital del Mar, and Western University, where his work in EEG and cerebrovascular illness has helped shape the careers of future neurologists.

 Research Focus

His research primarily focuses on epilepsy and ischemic cerebrovascular diseases. His PhD thesis, which examined markers of recurrence in intracranial atherostenosis, highlights his dedication to improving diagnostics and treatment outcomes in neurology. He continues to contribute to research on epilepsy and cerebrovascular conditions, aiming to reduce the recurrence of ischemic events in patients.

 

📖Publications : 

  • 📄 “Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program”
    Author: Massot-Tarrús, A.
    Journal: Epilepsia Open
    Year: 2023
    Volume: 8(3), pp. 918–929
  • 📊 “Risk factors for comorbid epilepsy in patients with psychogenic non-epileptic seizures. Dataset of a large cohort study”
    Author: Massot-Tarrús, A.
    Journal: Data in Brief
    Year: 2022
    Volume: 45, 108568
  • 🧠 “Roles of fMRI and Wada tests in the presurgical evaluation of language functions in temporal lobe epilepsy”
    Author: Massot-Tarrús, A.
    Journal: Frontiers in Neurology
    Year: 2022
    Volume: 13, 884730
  • 💊 “Perampanel as adjuvant treatment in epileptic encephalopathies: A multicenter study in routine clinical practice”
    Co-author: Massot-Tarrús, A.
    Journal: Epilepsy and Behavior
    Year: 2022
    Volume: 134, 108836
  • 📈 “Factors associated with comorbid epilepsy in patients with psychogenic nonepileptic seizures: A large cohort study”
    Author: Massot-Tarrús, A.
    Journal: Epilepsy and Behavior
    Year: 2022
    Volume: 134, 108780
  • 🧩 “Cortical myoclonus associated with coeliac disease showing a characteristic EEG pattern: A case report”
    Author: Massot-Tarrús, A.
    Journal: Seizure
    Year: 2022
    Volume: 95, pp. 81–83
  • 🚑 “Response to anakinra in new-onset refractory status epilepticus: A clinical case”
    Author: Massot-Tarrús, A.
    Journal: Seizure
    Year: 2022
    Volume: 94, pp. 92–94
  • 🦠 “Neurological complications of COVID-19 in hospitalized patients: The registry of a neurology department in the first wave of the pandemic”
    Co-author: Massot-Tarrús, A.
    Journal: European Journal of Neurology
    Year: 2021
    Volume: 28(10), pp. 3339–3347
  • 📉 “Predicting outcome of patients with psychogenic nonepileptic seizures after diagnosis in an epilepsy monitoring unit”
    Author: Massot-Tarrús, A.
    Journal: Epilepsy and Behavior
    Year: 2021
    Volume: 120, 108004
  • 🧬 “E200K familial Creutzfeldt-Jakob disease. MRI, EEG, PET and neuropathological correlation in a family”
    Co-author: Massot-Tarrús, A.
    Journal: Neurologia
    Year: 2021
    Volume: 36(5), pp. 399–401

 

Marjan Shariatpanahi | Neuroscience | Best Researcher Award

Dr Marjan Shariatpanahi |  Neuroscience | Best Researcher Award 

Associate professor at Iran university of medical sciences,Iran

Dr. Marjan Shariatpanahi is an Associate Professor in the Department of Pharmacology and Toxicology at the School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran. With extensive experience in toxicology and pharmacology, Dr. Shariatpanahi has made significant contributions to research on neurodegenerative diseases and toxicology.

professional profile

scopus

google scholar

Education 🎓

Dr. Shariatpanahi holds a Doctor of Pharmacy (Pharm. D.) from Islamic Azad University, Tehran (2000-2006) with a thesis on thymidine phosphorylase and estrogen receptor alpha in colorectal cancer. She also earned a Ph.D. in Toxicology from Tehran University of Medical Sciences (2009-2014), focusing on the effects of PKG on spatial memory deficits and markers of autophagy and apoptosis in rats.

Work Experience 🏥

Dr. Shariatpanahi has a diverse professional background. She has been the Head of the Pharmacology & Toxicology Department at Iran University of Medical Sciences since 2017. Her previous roles include Dean of the Educational Office (2020-2023), Head of Student and Cultural Affairs (2019-2020), and faculty member at the Neuroscience Research Center (2018-present). She has also worked as an Assistant Professor at both Iran University of Medical Sciences and Guilan University of Medical Sciences, and as a Responsible Pharmacist in various institutions.

Skills 🛠️

Dr. Shariatpanahi is proficient in various research techniques, including IHC, Western blot, ICC, in vivo studies, and behavioral tests for neurodegenerative diseases. Her expertise extends to TLC, spectrophotometry, SPSS, PRISM, ELISA, and gas chromatography. She is also skilled in using atomic absorption machines and Endnote.

Awards and Honors 🏅

Dr. Shariatpanahi has received several accolades, including being named the best professor at the Vosough Festival of IUMS (2023) and being recognized as a selected pharmacist (2022). She was also acknowledged as a top student in toxicology and pharmacy, receiving first ranks in board examinations and seminars.

Professional Memberships 🔗

Dr. Shariatpanahi is a member of the Iranian Association of Toxicology, the Iranian Medical Council, the Iranian Association of Pharmacists, the Iranian Probiotics Society, and the Talent Society of Tehran University.

Teaching Experience 📚

Dr. Shariatpanahi has taught a wide range of courses across various levels. For Ph.D. students, she covers basics of pharmacology. For Doctor of Pharmacy students, she teaches toxicology, pharmacology, clinical toxicology, and specialized pharmacy language. Her M.Sc. teaching includes environmental toxicology, forensic toxicology, and advanced research methods, while for B.Sc. students, she focuses on toxicology.

Research Focus 🔬

Dr. Shariatpanahi’s research interests include neuroscience, with a focus on autism, Alzheimer’s disease, memory, and Parkinson’s disease. She is also involved in toxicology, environmental toxicology, pharmacology, cell signaling, stem cell therapy, and the study of behavioral investigations on animals. Her work explores various markers and mechanisms in carcinogenesis, angiogenesis, and the protective and toxic effects of nanoparticles.

Conclusion

Dr. Marjan Shariatpanahi’s extensive qualifications, leadership roles, significant research contributions, and recognition in the field make him an excellent candidate for the Best Researcher Award. His achievements demonstrate a strong commitment to advancing knowledge in pharmacology and toxicology, contributing valuable insights into neurodegenerative diseases, toxicology, and pharmacology.

publication